gvtcx

supplier

Milpharm Ltd/aurobinbdo

HA46QD

as a supplier

19 recorded awards from 3 buyers , between 21 Dec 2020 and 6 Jul 2023.

awards won
19
exclusive
0%
0 sole-winner awards
median award
£428.2m
largest
£469.7m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

buyerawards
The NHS Commissioning Board (operating under the name of NHS England) 13
NHS England 4
Atamis Ltd 2

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,550 30 Nov 2021
NHS National Generic Pharmaceuticals Interim 2 shared NHS England £12,327,097 21 Dec 2020
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & provision of a service to supply over labelled PrEP and PEP packs (Lot 2) 1 November 2024 shared NHS England · 28 Nov 2024
NHS National Generics Pharmaceuticals Transition 2023_1 shared NHS England · 24 May 2023
NHS National Generics Pharmaceuticals Transition 2023_1 shared NHS England · 24 May 2023
NHS National Generic Pharmaceuticals Wave 13 shared The NHS Commissioning Board (operating under the name of NHS England) · 14 Jan 2022
NHS National Generic Pharmaceuticals Wave 13 shared The NHS Commissioning Board (operating under the name of NHS England) · 14 Jan 2022
NHS National Pharmaceuticals - Everolimus and terminated agreement products shared The NHS Commissioning Board (operating under the name of NHS England) · 28 Sept 2021
NHS National Pharmaceuticals - Everolimus and terminated agreement products shared The NHS Commissioning Board (operating under the name of NHS England) · 28 Sept 2021
NHS National Pharmaceuticals - Everolimus and terminated agreement products shared The NHS Commissioning Board (operating under the name of NHS England) · 28 Sept 2021
NHS national Generic Pharmaceuticals Transition 2021_2 shared The NHS Commissioning Board (operating under the name of NHS England) · 4 Jun 2021
NHS national Generic Pharmaceuticals Transition 2021_2 shared The NHS Commissioning Board (operating under the name of NHS England) · 4 Jun 2021
NHS national Generic Pharmaceuticals Transition 2021_2 shared The NHS Commissioning Board (operating under the name of NHS England) · 4 Jun 2021
NHS national Generic Pharmaceuticals Transition 2021_2 shared The NHS Commissioning Board (operating under the name of NHS England) · 4 Jun 2021
NHS national Generic Pharmaceuticals Transition 2021_2 shared The NHS Commissioning Board (operating under the name of NHS England) · 4 Jun 2021
NHS national Generic Pharmaceuticals Transition 2021_2 shared The NHS Commissioning Board (operating under the name of NHS England) · 4 Jun 2021
NHS National Generic Pharmaceuticals Interim 2 2020 shared The NHS Commissioning Board (operating under the name of NHS England) · 3 Feb 2021
NHS National Generic Pharmaceuticals Interim 2 2020 shared The NHS Commissioning Board (operating under the name of NHS England) · 3 Feb 2021

every contract won by Milpharm Ltd/aurobinbdo →